Stock Research: Baxter

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Baxter

NYSE:BAX US0718131099
26
  • Value
    43
  • Growth
    24
  • Safety
    Safety
    100
  • Combined
    64
  • Sentiment
    4
  • 360° View
    360° View
    26
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Baxter International Inc. is a global medtech company providing a portfolio of diagnostic, critical care, nutrition, hospital, and surgical products. It operates in the medical products and therapies, healthcare systems and technologies, and pharmaceuticals industries. In the last fiscal year, the company had a market cap of $14,497 million, profits of $4,046 million, revenue of $10,636 million, and 38000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 26 (better than 26% compared with alternatives), overall professional sentiment and financial characteristics for the stock Baxter are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Baxter. Only the consolidated Value Rank has an attractive rank of 100, which means that the share price of Baxter is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 100% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 24, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 43, meaning the company has a riskier financing structure than 57% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 96% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 4. ...read more

more
Index
Dividends USA
Energy Efficient
Diversity USA
Low Waste
Recycling
SDG 12
SDG 3
SDG 6
D.J. US Medical Equipment
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 94 98 89
Growth
24 25 9 91
Safety
Safety
43 27 44 98
Sentiment
4 50 40 38
360° View
360° View
26 38 36 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
1 3 5 45
Opinions Change
7 50 31 23
Pro Holdings
n/a 66 67 30
Market Pulse
79 83 82 90
Sentiment
4 50 40 38
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 94 98 89
Growth
24 25 9 91
Safety Safety
43 27 44 98
Combined
64 30 51 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
79 55 64 50
Price vs. Earnings (P/E)
82 57 74 48
Price vs. Book (P/B)
77 52 41 44
Dividend Yield
98 90 96 94
Value
100 94 98 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
19 55 27 69
Profit Growth
56 39 19 60
Capital Growth
58 24 51 62
Stock Returns
14 37 39 79
Growth
24 25 9 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
19 18 13 46
Refinancing
67 43 69 97
Liquidity
60 61 60 84
Safety Safety
43 27 44 98

Similar Stocks

Discover high‑ranked alternatives to Baxter and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.